Prediction of obstetric outcomes in sickle cell patients based on tricuspid regurgitant velocity
{{output}}
Background: Transthoracic echocardiography, a validated tool for risk assessment in non-pregnant population with sickle cell disease (SCD), uses tricuspid regurgitant velocity (TRV) over 2.5 m/s is an independent mortality risk f... ...
